Intermountain Precision Genomics, a St. George, Utah-based lab of Salt Lake City-based Intermountain Healthcare, launched the DNA-based RxMatch Anti-Depressant Panel Sept. 5.
GLP-1s
The opioid epidemic is a complex issue that will require a multipronged approach to address, according to Doug Nemecek, MD, MBA, CMO of behavioral health for Bloomfield, Conn.–based Cigna.
The number of Americans dying from opioid overdoses is staggering. In 2015, a record 52,404 people in the U.S. died from drug overdoses. The rise in deaths was largely driven the 33,000 deaths attributable to opioids — a record number,…
Millennials are half as likely as baby boomers to use opioids for pain relief, a new survey, commissioned by the American Society of Anesthesiologists, shows.
Prescient Medicine created a genetic test to assess individual risk of opioid addiction, according to a study published in Annals of Clinical & Laboratory Science.
Advertisement
Researchers with the Scripps Research Institute in La Jolla, Calif., are working on vaccines for heroin and fentanyl addiction, according to Seeker.
Indianapolis-based Anthem and its affiliated health plans achieved a companywide target of reducing filled opioid prescriptions by 30 percent two years before a 2019 deadline.
OptumRx, a pharmacy care services company, said its Opioid Risk Management program has reduced opioid consumption and prescribing since its launch July 1, according to initial results released Tuesday.
After nonfatal overdoses, Medicaid patients in Pennsylvania demonstrated a minimal reduction in prescription opioid use and a marginal increase in medication-assisted addiction treatment from 2008 to 2013, according to a study published in JAMA.
Salt Lake City-based Intermountain Healthcare aims to achieve a 40 percent reduction in the number of opioids prescribed for acute pain systemwide by the end of 2018.